These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20814356)

  • 1. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients.
    Zarkhin V; Talisetti A; Li L; Wozniak LJ; McDiarmid SV; Cox K; Esquivel C; Sarwal MM
    Transplantation; 2010 Nov; 90(9):1000-5. PubMed ID: 20814356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation.
    Baştürk B; Karakayali F; Emiroğlu R; Sözer O; Haberal A; Bal D; Haberal M
    Transplant Proc; 2006 Mar; 38(2):571-4. PubMed ID: 16549178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble human leukocyte antigen-G in pediatric renal transplantation.
    Zarkhin V; Bezchinsky M; Li L; Sarwal MM
    Transplantation; 2011 Jul; 92(1):e1-2. PubMed ID: 21691191
    [No Abstract]   [Full Text] [Related]  

  • 4. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
    Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
    Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
    Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA-G: immunoregulatory molecule involved in allograft acceptance].
    Creput C; Durrbach A; Charpentier B; Carosella ED; Rouas-Freiss N
    Nephrologie; 2003; 24(8):451-6. PubMed ID: 14737978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients.
    Stenard F; Nguyen C; Cox K; Kambham N; Umetsu DT; Krams SM; Esquivel CO; Martinez OM
    Pediatr Transplant; 2009 Feb; 13(1):70-80. PubMed ID: 18331536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients.
    McMillan RW; Gelder FB; Zibari GB; Aultman DF; Adamashvili I; McDonald JC
    Clin Transplant; 1997 Apr; 11(2):98-103. PubMed ID: 9113444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients.
    Le Rond S; Le Maoult J; Créput C; Menier C; Deschamps M; Le Friec G; Amiot L; Durrbach A; Dausset J; Carosella ED; Rouas-Freiss N
    Eur J Immunol; 2004 Mar; 34(3):649-660. PubMed ID: 14991594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.
    Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J
    Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
    Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
    J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
    Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
    Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-G in organ transplantation].
    Le Maoult J; Rouas-Freiss N; Le Discorde M; Moreau P; Carosella ED
    Pathol Biol (Paris); 2004 Mar; 52(2):97-103. PubMed ID: 15001239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique aspects of rejection and tolerance in liver transplantation.
    Knechtle SJ; Kwun J
    Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.